Here we report that mouse skeletal muscle can propagate prions and accumulate substantial titers of these pathogens. We found both high prion titers and the disease-causing isoform of the prion protein (PrP Sc ) in the skeletal muscle of wild-type mice inoculated with either the Me7 or Rocky Mountain Laboratory strain of murine prions. Particular muscles accumulated distinct levels of PrP Sc , with the highest levels observed in muscle from the hind limb. To determine whether prions are produced or merely accumulate intramuscularly, we established transgenic mice expressing either mouse or Syrian hamster PrP exclusively in muscle. Inoculating these mice intramuscularly with prions resulted in the formation of high titers of nascent prions in muscle. In contrast, inoculating mice in which PrP expression was targeted to hepatocytes resulted in low prion titers. Our data demonstrate that factors in addition to the amount of PrP expressed determine the tropism of prions for certain tissues. That some muscles are intrinsically capable of accumulating substantial titers of prions is of particular concern. Because significant dietary exposure to prions might occur through the consumption of meat, even if it is largely free of neural and lymphatic tissue, a comprehensive effort to map the distribution of prions in the muscle of infected livestock is needed. Furthermore, muscle may provide a readily biopsied tissue from which to diagnose prion disease in asymptomatic animals and even humans.
Considerable evidence argues that consumption of beef products from cattle infected with bovine spongiform encephalopathy (BSE) prions causes new variant Creutzfeldt-Jakob disease. In an effort to prevent new variant Creutzfeldt-Jakob disease, certain ''specified offals,'' including neural and lymphatic tissues, thought to contain high titers of prions have been excluded from foods destined for human consumption [ Here we report that mouse skeletal muscle can propagate prions and accumulate substantial titers of these pathogens. We found both high prion titers and the disease-causing isoform of the prion protein (PrP Sc ) in the skeletal muscle of wild-type mice inoculated with either the Me7 or Rocky Mountain Laboratory strain of murine prions. Particular muscles accumulated distinct levels of PrP Sc , with the highest levels observed in muscle from the hind limb. To determine whether prions are produced or merely accumulate intramuscularly, we established transgenic mice expressing either mouse or Syrian hamster PrP exclusively in muscle. Inoculating these mice intramuscularly with prions resulted in the formation of high titers of nascent prions in muscle. In contrast, inoculating mice in which PrP expression was targeted to hepatocytes resulted in low prion titers. Our data demonstrate that factors in addition to the amount of PrP expressed determine the tropism of prions for certain tissues. That some muscles are intrinsically capable of accumulating substantial titers of prions is of particular concern. Because significant dietary exposure to prions might occur through the consumption of meat, even if it is largely free of neural and lymphatic tissue, a comprehensive effort to map the distribution of prions in the muscle of infected livestock is needed. Furthermore, muscle may provide a readily biopsied tissue from which to diagnose prion disease in asymptomatic animals and even humans. P rions cause neurodegenerative diseases, including CreutzfeldtJakob disease (CJD), bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD), and scrapie in mammals (1) . The only known constituent of the infectious prion is an aberrant isoform (PrP Sc ) of the normal cellular (PrP C ) prion protein (PrP). PrP C is a cell-surface glycoprotein, the expression of which is necessary for the production of prions (2, 3) . In animals with clinical signs of scrapie, the highest levels of prions are found in the brain and spinal cord, but other tissues, particularly those of the reticuloendothelial system, exhibit substantial prion titers (4, 5) .
It is important that animal tissues bearing high prion titers be excluded from the human food supply. Transmission of prions by oral ingestion of infected tissues is well documented in rodents and more recently in cattle and sheep (6) (7) (8) . The efficiency of transmission of prion disease between species is governed by a phenomenon commonly known as the ''species barrier.'' This barrier is influenced by differences in the amino acid sequence of PrP between the species (9), but recent data clearly demonstrate that the barrier to prion transmission between any two species also depends on the particular prion strain (10) . As yet, a reliable procedure of experimentally or theoretically predicting the barrier to prion transmission from prion-infected animals to humans does not exist. Although BSE prions have been transmitted to teenagers and young adults from infected cattle (10, 11) and kuru was transmitted among humans by ritualistic cannibalism (12, 13) , it remains unclear whether cervid prions in North America have been transmitted to humans (14, 15) . Animal muscle composes a substantial portion of the human diet, but whether prions can be found in muscle has not been thoroughly examined using sensitive assays (16) (17) (18) (19) .
We report here that prions propagate and accumulate in skeletal muscle in a region-specific manner, and at levels much higher than have been generally assumed (19) (20) (21) .
Materials and Methods
Detection of PrP Sc in Skeletal Muscle. Muscle tissue was pulverized under liquid nitrogen, suspended to 10% in PBS, then subjected to 10 strokes of a Potter-Elvehjem homogenizer. For protease digestion, an equal volume of 4% Sarkosyl in PBS was added to 1-4 ml of the homogenate, and proteinase K (PK) was added at a ratio of 1:50, PK to homogenate protein. The sample was incubated at 37°C for 1 h with rocking, followed by the addition of a proteinase inhibitor mixture (Complete, Roche Molecular Biochemicals). Phosphotungstic acid precipitation was performed as described (22) , except that samples were subjected to centrifugation at 20,000 ϫ g at 4°C for 1 h in a fixed angle rotor.
Western blotting and PrP detection were performed as described (23 For PrP Sc detection using ELISA, PK-digested muscle homogenates were denatured with 6 M guanidine thiocyanate after centrifugation described above. Subsequently denatured homogenates were immobilized on the surface of a 96-well Immulon II ELISA plate (Dynex, Franklin, MA) and the rest of the surface was blocked by 3% BSA. Detection of PrP Sc was carried out by a 2-h incubation of HuM-D18 Ab (24) in 1ϫ Tris buffered saline, followed by 1-h incubation with goat anti-human Fab Ab conjugated to alkaline phosphatase (Pierce). An additional 1-h incubation used 1-step pNPP (Pierce), an alkaline phosphatase substrate for the development of a colored product, which can be measured at 405 nm. Determination of Prion Titers. Prion titers in organ homogenates were determined by an incubation time assay. Tissue from Tg(MCK-SHaPrP)8775͞Prnp 0/0 mice (Tg, transgenic; MCK, muscle creatine kinase; SHa, Syrian hamster), which express SHaPrP, were assayed in Syrian hamsters (25, 26) . Tissues from Tg(␣-actinMoPrP)6906͞Prnp 0/0 (Mo, mouse) and Tg(TTR-MoPrP)8332͞ Prnp 0/0 mice (TTR, transthyretin), which express mouse PrP, were assayed in Tg(MoPrP)4053͞FVB mice, a Tg line that overexpresses mouse Prnp a (27) . The relationship between incubation time and prion titer for Tg(MoPrP)4053͞FVB, using the RML prion strain, is log titer (ID 50 units͞g) ϭ 1 ϩ 32.189⅐e (Ϫ0.0278⅐(mean inc. time (days) ) (23) . Incubation time assays are less accurate at estimating low prion titers than high titers. The convention applied in this article was to estimate titers to be less than 10 3 ID 50 units͞g if some, but not all, inoculated animals became ill, and titers to be less than 10 2 ID 50 units͞g if no animals became ill. An alternative estimate of low titers can be obtained by assuming that because (0.5 t ) N is the chance that no inoculated animals develop disease (in which N is the number of animals inoculated and t is ID 50 unit titer per inoculum), the maximum titer that has at least a 5% chance of zero transmissions is 0.43 units per inoculum, or about 10 3.2 ID 50 units͞g tissue, which is therefore the lower limit of the sensitivity of the assay. In some bioassays of Sc237 prions, all i.c. inoculated hamsters developed disease, but prion titers calculated from equations describing standard curves of mean incubation time vs. the titer resulted in estimated values significantly lower than 1 ID 50 unit per inoculation. In these cases, prion titers were reported as calculated to allow comparison with other experiments. Actual titers were likely to be significantly higher, because if all animals developed disease, the titer should be greater than the minimum necessary to result in at least a 5% chance that all inoculated animals would become ill. This value is 1.7 ID 50 units per inoculum, or about 10 Transgene Constructs MCK-SHaPrP. A 3.3-kbp fragment of the promoter͞enhancer region of the mouse MCK gene directs chloramphenicol acetyl transferase (CAT) expression to skeletal muscle and myocardium (28) . We replaced the ␤-galactosidase coding sequence in pNASS-beta (CLONTECH) with the coding sequence for fulllength SHaPrP and ligated the MCK promoter͞enhancer into the XhoI site of the vector. In the completed construct, SV40 splice donor and acceptor sites are situated between the MCK promoter and the SHa ORF. This ''artificial intron'' may increase expression of the transgene (29).
␣-Actin-MoPrP. A fragment of the chicken ␣-actin gene, extending from position Ϫ191 to position ϩ27 relative to the transcriptional start site, directs expression of a chloramphenicol acetyl transferase gene to skeletal muscle (30) . We ligated this 218-bp fragment to a derivative of the mouse PrP gene in which the promoter͞enhancer elements and the 12-kbp second intron had been deleted (31) .
TTR-MoPrP.
An approximately 300-bp sequence containing the promoter and an enhancer sequence from the mouse TTR gene was linked to the same modified fragment of the mouse PrP gene used in the ␣-actin-MoPrP construct described above. The TTR promoter͞enhancer sequence used had been demonstrated to direct expression to the liver and brain, with occasional expression in the kidney (32) .
Microinjections and Screening. The transgene constructs were introduced into FVB͞Prnp 0/0 mice. Incorporation of the ␣-actin-MoPrP and TTR-MoPrP transgenes was detected by hybridization of tail DNA with a murine PrP-specific probe, whereas the presence of the MCK-SHaPrP transgene was determined by PCR on tail DNA using primers that amplify across the MCK-SHaPrP junction.
Analysis of PrP Expression. Organ homogenates were prepared in PBS. For skeletal muscle, we homogenized the proximal hindlimb muscles. After determining the protein concentration by the bicinchoninic acid (BCA) assay (Pierce), indicated amounts of total protein were analyzed by Western blotting according to standard procedures (33) with a chemiluminescent detection system (ECL, Amersham Biosciences). Blots were probed with R073, a polyclonal rabbit antiserum that recognizes mouse and hamster PrP (34); HuM-D13, a recombinant Ab recognizing mouse PrP (24); 3F4, a mAb that recognizes hamster but not mouse PrP (35); or HuM-P, a recombinant Ab that recognizes bovine PrP (J. Safar, personal communication). We determined PrP expression levels by visual inspection of serial dilutions of the appropriate homogenates on Western blots.
Results

Substantial Prion Titers in Muscle.
Because PrP C expression is essential for prion propagation, we first used Western blot analysis to confirm that in both mice and cattle (Bos taurus), PrP C is expressed in skeletal muscle, at a level about 5-10% of that in brain ( Fig. 1; refs. 36 and 37). We then used an incubation time assay to determine the prion titers in the hindlimb muscle of FVB mice showing signs of disease. Muscle harvested from mice killed 128 days after i.c. inoculation with RML prions harbored titers of 10 5 -10 6 ID 50 units͞g (Table 1) . These surprisingly high titers of prions in muscle do not represent a general contamination of mouse organs with brain-derived prions because homogenates of liver, an Serial dilutions of brain homogenate from a single animal were compared with dilutions of muscle homogenates from two animals obtained from a different source. The amount of PrP C found in 25 g of muscle homogenate is slightly greater than that seen in 1.3 g of brain homogenate; therefore, we conclude that PrP C expression in muscle is Ϸ5-10% of that in brain. The PrP C derived from muscle in this blot migrated faster than that derived from brain because the muscle is from cattle bearing a 5-octarepeat PRNP allele, whereas brain is derived from an animal with the 6-octarepeat allele (50) .
organ that in wild-type (wt) mice expresses almost no PrP C (38) , from these same mice either failed to transmit scrapie or transmitted to only a few mice, indicating titers of 10 3 ID 50 units͞g or less. Previous studies demonstrated that brain prion titers in mice exhibiting signs of prion infection are typically 10 9 -10 10 ID 50 units͞g (23) when assayed in Tg(MoPrP)4053͞FVB mice.
PrP Sc Differentially Accumulates in Specific Muscle Groups. To confirm the high titers of infectious prions we found in skeletal muscle, we used Western immunoblots to detect the presence of protease-resistant PrP Sc . We initially examined the hindlimb muscle of wt CD-1 mice showing signs of neurologic disease 128 days after i.c. inoculation with RML prions (Fig. 2a) . Muscle homogenates from these mice, but not from uninoculated controls, displayed PK-resistant PrP Sc of an apparent molecular weight and glycoform ratio identical to that of PrP (Fig. 2b) . In contrast, we did not detect PrP Sc accumulation in the skeletal muscle from other regions, including head and neck, back, or forelimb, with an exception of the forelimb muscle from a single mouse (Fig. 2c) . To confirm the region-specific PrP Sc accumulation shown in the Western blot analysis, we measured the levels of PrP Sc by using ELISA, which gives more quantitative results than Western blotting (Table 2) . Only muscle from the hindlimbs of infected mice, and the forelimb muscle of the one mouse described above, had values significantly above background.
Intrinsic Prion Replication in Muscle.
Muscle tissue is composed of a variety of cell types (39) and is intimately associated with neural tissue. To determine whether prions replicate in myofibers, we constructed two lines of Tg mice that express PrP only under the control of myocyte-specific promoters. For each line, we introduced transgenes into FVB mice in which the chromosomal PrP gene had been disrupted (Prnp (Fig. 3b) .
We inoculated the Tg mice and non-Tg littermates i.m. in the left hindlimb with prions and then killed the mice at various times after inoculation. Tg(MCK-SHaPrP)8775͞Prnp 0/0 mice were inoculated with hamster Sc237 prions. We inoculated Tg(␣-actinMoPrP)6906͞Prnp 0/0 mice with RML prions and in parallel, inoculated FVB͞Prnp 0/0 mice, which are incapable of propagating prions (2, 3), with the same prion strain. We used incubation time assays to determine prion titers in homogenates of muscle from the hindlimb contralateral to the inoculated one, the brain, and the spleen.
From Tg(␣-actin-MoPrP)6906͞Prnp 0/0 mice inoculated with RML prions, we found titers of Ͼ10 7 ID 50 units͞g in muscle, obtained at 350 days after inoculation. Titers were generally lower in muscles of Tg(MCK-SHaPrP)8775͞Prnp 0/0 mice inoculated with Sc237 prions, at Ϸ10 4 ID 50 units͞g in two mice and Ϸ10 8 ID 50 units͞g in another mouse, all three of which were killed 413 days after inoculation (Table 3 ). The muscle prion titer in a fourth mouse killed 76 days after inoculation was Ϸ10 We performed several experiments to confirm that the prions we Mice were killed when showing signs of neurologic illness, 128 days after intracerebral inoculation with RML prions. *n, no. of animals diagnosed ill with scrapie; n 0, no. of animals inoculated. † Determined by incubation time assay in Tg(MoPrP)4053͞FVB mice. 3, and 5 ). Two milligrams of PK-digested muscle homogenates and about 60 g of undigested muscle homogenates were used for analysis. (c) Muscle tissue from the head-neck (HN), back (B), and forelimb (FL) of the mice analyzed in b were collected at the time that the hindlimb muscle was collected. Lanes were loaded with PK-digested (even-numbered lanes) and undigested muscle homogenates (odd-numbered lanes). The analytical method was the same as that described in b. All blots were probed with the HuM-D13 Ab.
found in muscle were formed therein. Results from two experiments exclude residual inoculum as the source of the prions that we measured. First, we detected no prions in the muscle of the (Table 4) . Prions disappeared equally rapidly from both lines. Moreover, the levels of prions found ipsilateral to the injection site at 28 days after inoculation in Tg(MCK-SHaPrP)8775͞Prnp 0/0 mice were at least 10-fold lower than the levels found contralateral to the injection site in mice killed at later times, indicating de novo prion synthesis (compare Tables 3 and 4) .
To exclude the possibility that the prions found in muscle were contaminants produced elsewhere in our mice, we determined prion titers in the brains and spleens of Tg mice inoculated i. (Fig. 3c) , with higher PrP levels in liver than in brain. We inoculated the mice i.c. with RML prions and killed them when they developed signs of disease at 296 days. To test the influence of inoculation site, we also inoculated Tg(TTRMoPrP)8332͞Prnp mice inoculated i.p. with RML prions never appeared ill and were killed 523 days after inoculation. Hepatic prion titers in the mice inoculated i.p. were similar to those of mice inoculated i.c. Although hepatic prion titers were low, it does seem that expressing high levels of PrP C in liver enhances prion formation, because liver homogenates from Tg(TTR-MoPrP)8332͞ Prnp 0/0 mice inoculated with RML prions transmitted disease to significantly more mice than did liver homogenates from RMLinoculated FVB mice (Tables 1 and 3 ; P Ͻ 0.001, Fisher exact test).
From these data, we conclude that different cell types accumulate prions with markedly different efficiencies, even when PrP *P values were calculated by comparing all muscle of uninoculated mice to muscle of the indicated region from all inoculated mice, using the t test with an alpha of 0.0125 to correct for multiple comparisons. † Mean and SD were obtained from duplicates or triplicates of ELISA. Nos. without SD were obtained from single ELISA determinations. (38) who concluded that prions failed to propagate in hepatocytes or T cells of Tg mice that express PrP in these cell types. However, the authors stated that the levels of PrP expression achieved in the livers of their mice were quite low and that the absence of detectable prions in circulating T cells might have been caused by loss of prion-infected cells during natural turnover or because of prion-related toxicity.
Discussion
Our studies demonstrate that mouse skeletal muscle is intrinsically capable of propagating prions, that titers at least as high as 10 7 ID 50 units͞g can accumulate in muscle, and most surprisingly, that the efficiency of this accumulation varies markedly among groups of muscles taken from different regions of the body. Our finding of prion accumulation in skeletal muscle seems unambiguous, in that we obtained similar results with two different prion strains in wt mice and in Tg mice expressing PrP C almost exclusively in skeletal muscle. Why prions accumulate more efficiently in certain muscles than in others is not clear. However, different skeletal muscle groups demonstrate differential susceptibility to a number of disease processes, a property that presumably reflects biochemical differences in skeletal muscles of different body regions (45) . Studies in Tg mice (46) and cultured cells (43, 44) have implicated a cellular factor other than PrP, provisionally termed ''protein X,'' that is needed for the efficient propagation of prions. Perhaps only some skeletal muscles have sufficient amounts of protein X to enable the accumulation of high titers of prions. Similarly, the inefficient accumulation of prions in hepatic tissue demonstrated by our studies is further evidence of a role for an auxiliary factor such as protein X in prion propagation.
That high prion titers may be found in skeletal muscle even if central nervous system and lymphatic tissues are carefully excluded from the muscle raises the concern that humans consuming meat from prion-infected animals are at risk for acquiring infection. However, several caveats must be considered when assessing the risk of humans developing disease from prion-tainted meat. First, the efficiency of prion accumulation in muscle may vary with either the host species or the prion strain involved. Indeed, mouse RML prions seem to have accumulated more efficiently in muscle than did hamster Sc237 prions. Second, oral transmission is inefficient compared with the i.c. inoculations used for the bioassays reported in this study. In hamsters, oral exposure is 10 5 -to 10 9 -fold less efficient that the i.c. route (47, 48) . Finally, the species barrier must be considered. In many cases, efficient transmission of prions from one species to another requires a high degree of homology in the amino acid sequence of PrP between the two species. However, the degree to which amino acid sequence influences the efficiency of transmission depends on the strain of prion. In the case of new variant Creutzfeldt-Jakob disease (nvCJD) prions, Tg mice expressing bovine PrP C are much more susceptible to nvCJD prions, derived from human brain, than are Tg mice expressing either human or chimeric human-mouse PrP C (refs. 10 and 49; C. Korth and S.B.P., unpublished data).
Previous studies have generally reported low prion titers in muscle tissue. Some of these studies used inefficient cross-species transmissions, which might be responsible for their failure to detect prions in muscle (19) . Our investigations reveal another potential explanation for this failure. Because muscle prion accumulation varies between muscle groups or perhaps between specific muscles, previous studies may have failed to sample the muscles bearing the highest prion titers. If prions accumulate in certain muscles of humans with prion disease to levels near those that we found in mice with prion disease, it should be possible to definitively diagnose all forms of CJD and related disorders by using muscle tissue for biopsy. This approach would offer significant advantages over the relatively difficult and morbid brain biopsy procedure, which is currently the only way to definitively diagnose prion disease in humans.
Whether prions accumulate in skeletal muscle of cattle with BSE, of sheep with scrapie, or of deer and elk with chronic wasting disease remains to be established. However, our findings indicate that a comprehensive and systematic effort to determine the distribution of prions in the skeletal muscle of animals with prion disease is urgently needed. The distribution of prions in muscle may vary with the animal species, perhaps even with breeds, varieties, and lines within a species as well as with the strain of prions. Such assays need to be carried out by using sensitive and quantitative techniques, such as bioassays in Tg mice and quantitative immunoassays adapted to PrP Sc detection in muscle tissue.
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